MCA
ELV icon

Metropolitan Capital Advisors’s Elevance Health ELV Stock Holding History

Metropolitan Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,500
Closed -$1.1M – 44
2013
Q2 		$1.1M Buy
+13,500
New +$1.01M 1.4% 22

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Metropolitan Capital Advisors's ELV Position: Q4 2015 in Review

Metropolitan Capital Advisors reduced its Elevance Health (ELV) stake by 27% in Q4 2015, selling an estimated $1.7M and leaving 33,562 shares worth $4.68M. The position accounts for 9.3% of the portfolio, ranked #2.

Metropolitan Capital Advisors first reported a position in ELV in Q2 2013 and has held it in 11 quarters since. The position peaked at $7.51M in Q2 2015. 765 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

  • Metropolitan Capital Advisors held 33,562 shares of Elevance Health worth $4.68M as of Q4 2015.
  • Metropolitan Capital Advisors sold 12,375 Elevance Health shares in Q4 2015, an estimated $1.7M.
  • Elevance Health made up 9.3% of Metropolitan Capital Advisors's portfolio in Q4 2015, its #2 holding.
  • Metropolitan Capital Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 11 quarters since.
  • Metropolitan Capital Advisors's Elevance Health position peaked at $7.51M in Q2 2015.
  • 765 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Metropolitan Capital Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.